Category: State

Connecticut 340B stakeholders testified at a state legislative hearing Monday on Gov. Ned Lamont’s (D) comprehensive bill to require hospital reporting on 340B revenue, prohibit drug maker restrictions on 340B contract pharmacy use, and prohibit pharmacy benefit manager discrimination against

The chair of the New York Senate health committee has introduced legislation to repeal the April 1 shift of state Medicaid managed care pharmacy benefits to Medicaid fee for service. The state’s 340B health centers and Ryan White clinics say

Legislation in Indiana that would have required hospitals to file annual reports disclosing their median reimbursement for 340B-priced drugs, along with numerous other financial disclosures, has failed to advance and has no chance of passage this year.

The wide-ranging hospital

Identical bills have been introduced in the Iowa House and Senate to bar pharmacy benefit managers and insurers from using alleged discriminatory practices against 340B covered entities and their contract pharmacies, including reimbursing them at a lower rate or imposing

Connecticut’s Democratic governor wants his state’s 340B hospitals to start filing annual reports disclosing their 340B drug revenues and summarizing how they use the money to benefit their communities. Health centers and other 340B grantee covered entities would be exempt

Kansas lawmakers have introduced a bill to prohibit drug manufacturers from denying 340B covered entities access to a manufacturers’ products if the entities use contract pharmacies.

The legislation, like bills recently rolled out in other states, is modeled on the

A Virginia House subcommittee last week voted 3-2 against a Democrat’s bill to require more accountability from 340B hospitals about how they use 340B program revenues.

In a reversal of their parties’ normal stances on 340B nationally, Democrats voted for

Mississippi legislators have reintroduced legislation to stop drug manufactures from denying 340B covered entities access to the manufacturers’ products if the entity uses contract pharmacies.

Mississippi joins Missouri in making a second attempt to pass legislation modeled after the